Several studies have shown that chemotherapy can activate toll-like receptors 4 (TLR4), which exhibited an increase in proinflammatory IL-6 cytokine in blood and organs distant from the primary tumor in animal models and breast cancer patients [82]. This evidence concerns the gene TLR4 and neoplasm.